✦ LIBER ✦

Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection

✍ Scribed by Johannes Vermehren; Simone Susser; Annemarie Berger; Dany Perner; Kai-Henrik Peiffer; Regina Allwinn; Stefan Zeuzem; Christoph Sarrazin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1165 CLINICAL UTILITY OF THE ARCHITECT H

✍ Vermehren, J.; Süsser, S.; Berger, A.; Perner, D.; Peiffer, K.H.; Zeuzem, S.; Sa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Clinical performances of two real-time P

✍ Michelle Martinot-Peignoux; Hacène Khiri; Laurence Leclere; Sarah Maylin; Patric 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 495 KB

PIN32 Economic Evaluation of Boceprevir

✍ R. Odhiambo; J. Chhatwal; S.A. Ferrante; A. El Khoury; E. Elbasha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Peginterferon alfa-2b plus ribavirin for

✍ Stefan Zeuzem; Rolf Hultcrantz; Marc Bourliere; Tobias Goeser; Patrick Marcellin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Treatment of Chronic Hepatitis C Genotyp

✍ Sood, Ajit; Midha, Vandana; Goyal, Omesh; Sood, Neena; Sharma, Suresh 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 63 KB

The Treatment Efficacy of Pegylated Inte

✍ Huang, Ching-I; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Yeh, Ming-Lun; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB